Aniara Diagnostica is pleased to announce a comprehensive line of standardized ELISA Methods optimized for measuring Heparin- dependent antibodies of the IgG and IgGAM isotypes in human plasma.
WEST CHESTER, Pa. (PRWEB) November 23, 2018
Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery. Recently the company announced a new site hit-assay.com which highlights the availability of standardized ELISA Methods for the detection of Heparin-dependent antibodies.
ZYMUTEST™ HIA IgG
Enzyme Immuno-assay (HIT) designed for measuring Heparin-dependent antibodies of the IgG isotype, in human plasma.
ZYMUTEST™ HIA IgGAM
The ZYMUTEST™ HIA IgGAM kit is a screening assay that measures globally all human heparin-dependent antibodies of the IgG, IgM or IgA isotypes.
Aniara distributes Hyphen BioMed's entire line of diagnostic and research reagents for Thrombosis, Hemostasis, and Autoimmunity.
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.